Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 4 1

Status

Unknown 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostate Cancer With ≤10 Bone Metastases 1High-Risk and Oligometastatic Prostate Cancer 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Unknown × apalutamide × Clear all
NCT04997252 2024-03-18

An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer

Zhujiang Hospital

Phase NA Unknown
50 enrolled
Genitourinary

High-Risk and Oligometastatic Prostate Cancer

NCT05740488 2024-03-15

Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases

Zhujiang Hospital

Phase NA Unknown
30 enrolled
Genitourinary

Prostate Cancer With ≤10 Bone Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡